Literature DB >> 14652787

Biological markers of the inflammatory phase of multiple sclerosis.

A Uccelli1, E Pedemonte, E Narciso, G Mancardi.   

Abstract

The search for biological markers in multiple sclerosis (MS) has been spoiled by the intrinsic nature of the disease that occurs in a secluded organ which cannot be accessed by routine sampling. Thus, markers obtained so far from the peripheral blood of MS individuals are often of little reproducibility while results obtained from the cerebrospinal fluid (CSF) are conveniently linked to the disease process but of little utility due to inaccessibility to repeated sampling. In this review we briefly discuss the biological markers available to date.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14652787     DOI: 10.1007/s10072-003-0172-5

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  7 in total

Review 1.  Management of secondary-progressive multiple sclerosis.

Authors:  Gavin Giovannoni
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 2.  The emerging role of p38 mitogen-activated protein kinase in multiple sclerosis and its models.

Authors:  Dimitry N Krementsov; Tina M Thornton; Cory Teuscher; Mercedes Rincon
Journal:  Mol Cell Biol       Date:  2013-07-29       Impact factor: 4.272

3.  Quantitative proteomics and metabolomics analysis of normal human cerebrospinal fluid samples.

Authors:  Marcel P Stoop; Leon Coulier; Therese Rosenling; Shanna Shi; Agnieszka M Smolinska; Lutgarde Buydens; Kirsten Ampt; Christoph Stingl; Adrie Dane; Bas Muilwijk; Ronald L Luitwieler; Peter A E Sillevis Smitt; Rogier Q Hintzen; Rainer Bischoff; Sybren S Wijmenga; Thomas Hankemeier; Alain J van Gool; Theo M Luider
Journal:  Mol Cell Proteomics       Date:  2010-09       Impact factor: 5.911

Review 4.  Oxidative Stress and Neurobiology of Demyelination.

Authors:  Srdjan Ljubisavljevic
Journal:  Mol Neurobiol       Date:  2014-12-11       Impact factor: 5.590

5.  A multifactorial prognostic index in multiple sclerosis. Cerebrospinal fluid IgM oligoclonal bands and clinical features to predict the evolution of the disease.

Authors:  Jessica Mandrioli; Patrizia Sola; Roberta Bedin; Mariaelena Gambini; Elisa Merelli
Journal:  J Neurol       Date:  2008-06-13       Impact factor: 4.849

Review 6.  B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized Inflammation.

Authors:  Laure Michel; Hanane Touil; Natalia B Pikor; Jennifer L Gommerman; Alexandre Prat; Amit Bar-Or
Journal:  Front Immunol       Date:  2015-12-24       Impact factor: 7.561

7.  Activation of Transcription Factor 4 in Dendritic Cells Controls Th1/Th17 Responses and Autoimmune Neuroinflammation.

Authors:  Indumathi Manoharan; Daniel Swafford; Arulkumaran Shanmugam; Nikhil Patel; Puttur D Prasad; Muthusamy Thangaraju; Santhakumar Manicassamy
Journal:  J Immunol       Date:  2021-08-04       Impact factor: 5.426

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.